Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina B Emdal

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular & Cellular Oncology|January 30, 2020
Molecular switches in signaling networks as a mechanism of action for oncogenic mutations in proximity of tyrosine residuesKristina B Emdal, Alicia Lundby
Breast Cancer Research and Treatment|April 25, 2012
NFκB signaling is important for growth of antiestrogen resistant breast cancer cellsChristina W Yde, Kristina B Emdal, Barbara Guerra, et al.
Molecular Cancer Therapeutics|August 24, 2017
Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of ResistanceKristina B Emdal, Antje Dittmann, Raven J Reddy, et al.
Breast Cancer Research and Treatment|August 22, 2009
Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistanceKatrine Sonne-Hansen, Ida C Norrie, Kristina B Emdal, et al.
Nature|November 8, 2019
Dynamic lineage priming is driven via direct enhancer regulation by ERKWilliam B Hamilton, Yaron Mosesson, Rita S Monteiro, et al.
Cancer Discovery|December 6, 2017
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast CancerHui Liu, Charles J Murphy, Florian A Karreth, et al.
Science Signaling|November 22, 2018
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastomaKristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Science Signaling|April 30, 2015
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiationKristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Molecular Cell|September 10, 2013
Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputsChiara Francavilla, Kristoffer T G Rigbolt, Kristina B Emdal, et al.
Molecular Cancer Therapeutics|January 8, 2017
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific SensitivitiesBranka Radic-Sarikas, Kalliopi P Tsafou, Kristina B Emdal, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Oncology|January 30, 2020
Molecular switches in signaling networks as a mechanism of action for oncogenic mutations in proximity of tyrosine residuesKristina B Emdal, Alicia Lundby
Breast Cancer Research and Treatment|April 25, 2012
NFκB signaling is important for growth of antiestrogen resistant breast cancer cellsChristina W Yde, Kristina B Emdal, Barbara Guerra, et al.
Molecular Cancer Therapeutics|August 24, 2017
Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of ResistanceKristina B Emdal, Antje Dittmann, Raven J Reddy, et al.
Breast Cancer Research and Treatment|August 22, 2009
Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistanceKatrine Sonne-Hansen, Ida C Norrie, Kristina B Emdal, et al.
Nature|November 8, 2019
Dynamic lineage priming is driven via direct enhancer regulation by ERKWilliam B Hamilton, Yaron Mosesson, Rita S Monteiro, et al.
Cancer Discovery|December 6, 2017
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast CancerHui Liu, Charles J Murphy, Florian A Karreth, et al.
Science Signaling|November 22, 2018
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastomaKristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Science Signaling|April 30, 2015
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiationKristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Molecular Cell|September 10, 2013
Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputsChiara Francavilla, Kristoffer T G Rigbolt, Kristina B Emdal, et al.
Molecular Cancer Therapeutics|January 8, 2017
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific SensitivitiesBranka Radic-Sarikas, Kalliopi P Tsafou, Kristina B Emdal, et al.
Pageof 2